Back to search

Navidea Biopharmaceuticals Limited

07711916

active
Private Limited Company
Companies House
Health Score
80 / 100

Healthy

30/30
Filing
10/30
Financial
40/40
Risk

No risk factors detected.

Details

30 UPPER HIGH STREET, THAME, OX9 3EZ
Incorporated 20/07/2011

Compliance

Accounts

Up to date

Confirmation statement

Up to date

Industry

72110
Research and experimental development on biotechnology

Officers

Navidea Biopharmaceuticals Inc

director · Since 05/01/2022

Mr Michael Blue

director · Since 10/04/2023

CHIEF MEDICAL OFFICER

AMERICAN · UNITED STATES · Age 71

Mr Craig Dais

director · Since 28/07/2023

CFO

AMERICAN · UNITED STATES · Age 60

Persons with Significant Control

Navidea Biopharmaceuticals Inc

75–100% shares
75–100% votes

4100 Horizons Drive, Suite 205, Columbus, OH 43220

Reg: 31-1080091 · Register Of Companies · C-Corporation

Notified 06/04/2016

CompanyRankvs 2299+ SIC 72110 peers
39

Financial strength24th percentile among SIC peers · 6/25
Employees22th percentile among SIC peers · 3/15
LiquidityNo balance sheet data · 0/20
Longevity15 years trading (max 15) · 15/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
How is this score calculated?
Financial strength6/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees3/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity0/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity15/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/12/2024

Net Worth

£1

Balance sheet strength

Cash

Cash in the bank

Net Current Assets

-£78k

Working capital

Current Assets

Current Liabilities

£78k

0avg. employees
Prepared with CCH Software

EstimatesDerived

YearCurrent Ratio
20190.03
20180.03

Derived from filed accounts. Not audited figures.